Main Menu

ATM-A2 MILK

Started by Shareguy, Jun 24, 2022, 09:03 PM

Previous topic - Next topic

0 Members and 3 Guests are viewing this topic.

Left Field

#210
Quote from: winner (n) on Jan 06, 2023, 08:10 AMHey leftie ....share price up 80% from its reçent low ......not your 60%

Pretty cool eh

At 840, which isn't too far away, it be 100% up

Just like old times Winner!

Either way..... nice to be 'well positioned.'
"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)

winner (n)

Quote from: Left Field on Jan 06, 2023, 08:50 AMJust like old times Winner!

Either way..... nice to be 'well positioned.'


And owning more of the company because of the buyback

Winning all ways eh


winner (n)

I'm looking forward to half year numbers and comments

They said a while ago -'On track to achieve ambition to grow sales to $2 billion and improve EBITDA
margins over time'

After half year I might have to update this chart --- the sales line going to 2 billion in F26

You cannot view this attachment.

Left Field

#213
Stop posting such nice charts Winner...... you're getting me a tab excited.

(Must say your ATM chart is much nicer than the OCA v SUM chart you posted today..... crikey!)

"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)

Left Field

Bit of excitement in the SP today.

Talk-Less on HC posts...

A2 Platinum Stage 1 & 2 has received a letter of 'Enforcement Discretion' from the USA FDA

This confirms A2's intentions in the USA market and that it is taking steps to transition to more a permanent sales supply arrangement by demonstrating their IF meets approriate US standards.

Another brick in the wall.
"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)

Minimoke

Quote from: Left Field on Jan 13, 2023, 03:18 PMBit of excitement in the SP today.

Talk-Less on HC posts...

A2 Platinum Stage 1 & 2 has received a letter of 'Enforcement Discretion' from the USA FDA

This confirms A2's intentions in the USA market and that it is taking steps to transition to more a permanent sales supply arrangement by demonstrating their IF meets approriate US standards.

Another brick in the wall.

Its a long list of companies indicating they intend to stay. Nz's Danone is out. Australis Bubs remains keen

https://www.fda.gov/food/infant-formula-guidance-documents-regulatory-information/enforcement-discretion-manufacturers-increase-infant-formula-supplies

Left Field

#216
Seems ATM's possible expansion of IF sales into the USA is being encouraged by Forbar.

https://www.rnz.co.nz/news/national/483374/a2-milk-selling-infant-formula-in-us-could-help-improve-its-market-performance

It will be interesting to get ATM's view with their next market update .....

"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)

Minimoke

Quote from: Left Field on Jan 31, 2023, 04:45 PMSeems ATM's possible expansion of IF sales into the USA is being encouraged by Forbar.

https://www.rnz.co.nz/news/national/483374/a2-milk-selling-infant-formula-in-us-could-help-improve-its-market-performance

It will be interesting to get ATM's view with their next market update .....


I think it will add to brand recognition  and consumer trust. But I would really like to see an addition to profit line

Left Field

ATM's SP getting some interest today (so far) up about 9c or approx 1%.

According to Carlos G on HC NZ's December stats show the "export of IF and other stuff suitable for infants to China made all time record in terms of value ~ $145 mil in that month. Previous record was ~$129 mil in November 2020. An average for the previous 11 months was ~$82 mil with highest in September ~120 mil..... Seems price per kg also went up quite a bit in December"

"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)

Left Field

A positive step towards the next update.....

The a2 Milk Company ("a2MC") notes the announcement today by Synlait Milk Limited ("Synlait") in relation to the new national standards (GB) registration process for a2MC's China label infant milk formula products.

Synlait has announced that, as part of the registration process, Ministry for Primary Industries ("MPI") will commence the audit process of Synlait's Dunsandel facility on behalf of China's State Administration for Market Regulation ("SAMR") in the week of 20 February 2023.

The Company looks forward to providing a further update when its 1H23 results are released on Monday, 20 February.
"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)

Minimoke

Quote from: Left Field on Feb 17, 2023, 10:18 AMA positive step towards the next update.....

The a2 Milk Company ("a2MC") notes the announcement today by Synlait Milk Limited ("Synlait") in relation to the new national standards (GB) registration process for a2MC's China label infant milk formula products.

Synlait has announced that, as part of the registration process, Ministry for Primary Industries ("MPI") will commence the audit process of Synlait's Dunsandel facility on behalf of China's State Administration for Market Regulation ("SAMR") in the week of 20 February 2023.

The Company looks forward to providing a further update when its 1H23 results are released on Monday, 20 February.

Its really just an announcement of an upcoming announcement. There was never any doubt the audit would happen. And I have no doubts they will pass. But the market seems to like the announcement of not very much - up 6% today to $7.70

Left Field

Quote from: Minimoke on Feb 17, 2023, 01:34 PMIts really just an announcement of an upcoming announcement. There was never any doubt the audit would happen. And I have no doubts they will pass. But the market seems to like the announcement of not very much - up 6% today to $7.70

Agree..... no need to get excited yet. Much better to wait Monday's results update. Still the market is what the market is.
"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)

Minimoke

Quote from: Left Field on Feb 17, 2023, 01:43 PMAgree..... no need to get excited yet. Much better to wait Monday's results update. Still the market is what the market is.
They better be good. I've tried two supermarkets and can't get my milk any more. Not impressed! (Though I think Synlait now have their version on the shelves "Meadow fresh" for $7.85 rather an my usual $6.65)

Minimoke

Up 5.9% today to $7.75. Only 3 more sleeps. Monday is going to be very interesting.

(So far my hold firm to bail myself out of a hole seems to be working)

Left Field

#224
Results out....... I'm happy.... EPS up 24%..... Increased market share in China in a tough time when overall IF mkt down......onwards and upwards.

(Impressive gains in USA fresh milk sales etc)

... and this is v impressive....China & Other Asia sales up 54.0%, while ANZ sales down 24.6%, USA sales up 61.8% and MVM sales up 18.4%
- ChinalabelIMFsalesup 43.5%

http://nzx-prod-s7fsd7f98s.s3-website-ap-southeast-2.amazonaws.com/attachments/ATM/406946/388833.pdf

• Revenue growth of 18.6% to $783.3 million
- China & Other Asia sales up 54.0%, ANZ sales down 24.6%, USA sales up 61.8% and MVM sales up 18.4%
- IMF sales up 18.0% with China label sales up 43.5% and English label sales up 1.0%3
- Liquid milk sales in ANZ and USA up 5.6% and 62.0% respectively
• EBITDA4 up 10.5% to $107.8 million with an EBITDA to sales margin of 13.8%
• Net profit after tax (NPAT) including amounts attributable to non-controlling interests up 22.1% to $68.5 million with
$73.8 million5 attributable to owners of the Company
• Basic earnings per share up 24.1% to 10.0 cents compared to 8.0 cents in 1H22
• On-market share buyback of up to $150 million commenced in 1H23 and 60.1% complete
• Strong balance sheet with closing net cash6 of $707.2 million
• Outlook for FY23 revenue growth of low double-digit and EBITDA % margin similar to FY22. This is consistent with the prior update at the Company's Annual Meeting of Shareholders
"The difficulty lies not in new ideas... but in escaping from old ideas." (J M Keynes.)